Correlation Between Aileron Therapeutics and Motus GI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Motus GI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Motus GI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Motus GI Holdings, you can compare the effects of market volatilities on Aileron Therapeutics and Motus GI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Motus GI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Motus GI.

Diversification Opportunities for Aileron Therapeutics and Motus GI

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aileron and Motus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Motus GI Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Motus GI Holdings and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Motus GI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Motus GI Holdings has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Motus GI go up and down completely randomly.

Pair Corralation between Aileron Therapeutics and Motus GI

Given the investment horizon of 90 days Aileron Therapeutics is expected to generate 1.49 times more return on investment than Motus GI. However, Aileron Therapeutics is 1.49 times more volatile than Motus GI Holdings. It trades about 0.03 of its potential returns per unit of risk. Motus GI Holdings is currently generating about -0.04 per unit of risk. If you would invest  279.00  in Aileron Therapeutics on August 24, 2024 and sell it today you would lose (32.00) from holding Aileron Therapeutics or give up 11.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy32.06%
ValuesDaily Returns

Aileron Therapeutics  vs.  Motus GI Holdings

 Performance 
       Timeline  
Aileron Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aileron Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Aileron Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Motus GI Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Motus GI Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Motus GI is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Aileron Therapeutics and Motus GI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aileron Therapeutics and Motus GI

The main advantage of trading using opposite Aileron Therapeutics and Motus GI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Motus GI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Motus GI will offset losses from the drop in Motus GI's long position.
The idea behind Aileron Therapeutics and Motus GI Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes